These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25547792)

  • 21. Analysis of Spleen-Induced Fimbria Production in Recombinant Attenuated
    Łaniewski P; Baek CH; Roland KL; Curtiss R
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830946
    [No Abstract]   [Full Text] [Related]  

  • 22. Evaluation of Salmonella enterica serovar Typhimurium and Choleraesuis slyA mutant strains for use in live attenuated oral vaccines.
    Haneda T; Okada N; Kikuchi Y; Takagi M; Kurotaki T; Miki T; Arai S; Danbara H
    Comp Immunol Microbiol Infect Dis; 2011 Sep; 34(5):399-409. PubMed ID: 21840053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salmonella DIVA vaccine reduces disease, colonization and shedding due to virulent S. Typhimurium infection in swine.
    Bearson BL; Bearson SMD; Brunelle BW; Bayles DO; Lee IS; Kich JD
    J Med Microbiol; 2017 May; 66(5):651-661. PubMed ID: 28516860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An attenuated Salmonella enterica serovar Typhimurium strain lacking the ZnuABC transporter induces protection in a mouse intestinal model of Salmonella infection.
    Pesciaroli M; Aloisio F; Ammendola S; Pistoia C; Petrucci P; Tarantino M; Francia M; Battistoni A; Pasquali P
    Vaccine; 2011 Feb; 29(9):1783-90. PubMed ID: 21219981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella.
    De Benedetto G; Alfini R; Cescutti P; Caboni M; Lanzilao L; Necchi F; Saul A; MacLennan CA; Rondini S; Micoli F
    Vaccine; 2017 Jan; 35(3):419-426. PubMed ID: 27998639
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deletion of an immune evasion gene,
    Allen JC; Natta SS; Nasrin S; Toapanta FR; Tennant SM
    Front Immunol; 2024; 15():1376734. PubMed ID: 38911854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral immunization with ATP-dependent protease-deficient mutants protects mice against subsequent oral challenge with virulent Salmonella enterica serovar typhimurium.
    Matsui H; Suzuki M; Isshiki Y; Kodama C; Eguchi M; Kikuchi Y; Motokawa K; Takaya A; Tomoyasu T; Yamamoto T
    Infect Immun; 2003 Jan; 71(1):30-9. PubMed ID: 12496146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoclonal Antibodies of a Diverse Isotype Induced by an O-Antigen Glycoconjugate Vaccine Mediate In Vitro and In Vivo Killing of African Invasive Nontyphoidal Salmonella.
    Goh YS; Clare S; Micoli F; Saul A; Mastroeni P; MacLennan CA
    Infect Immun; 2015 Sep; 83(9):3722-31. PubMed ID: 26169269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reversible synthesis of colanic acid and O-antigen polysaccharides in Salmonella Typhimurium enhances induction of cross-immune responses and provides protection against heterologous Salmonella challenge.
    Li P; Liu Q; Huang C; Zhao X; Roland KL; Kong Q
    Vaccine; 2017 May; 35(21):2862-2869. PubMed ID: 28412074
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmonella Typhimurium TTSS-2 deficient mig-14 mutant shows attenuation in immunocompromised mice and offers protection against wild-type Salmonella Typhimurium infection.
    Pati NB; Vishwakarma V; Selvaraj SK; Dash S; Saha B; Singh N; Suar M
    BMC Microbiol; 2013 Oct; 13():236. PubMed ID: 24148706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Palmitoylation state impacts induction of innate and acquired immunity by the Salmonella enterica serovar typhimurium msbB mutant.
    Kong Q; Six DA; Liu Q; Gu L; Roland KL; Raetz CR; Curtiss R
    Infect Immun; 2011 Dec; 79(12):5027-38. PubMed ID: 21930761
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Highly Effective Component Vaccine against Nontyphoidal Salmonella enterica Infections.
    Ferreira RB; Valdez Y; Coombes BK; Sad S; Gouw JW; Brown EM; Li Y; Grassl GA; Antunes LC; Gill N; Truong M; Scholz R; Reynolds LA; Krishnan L; Zafer AA; Sal-Man N; Lowden MJ; Auweter SD; Foster LJ; Finlay BB
    mBio; 2015 Sep; 6(5):e01421-15. PubMed ID: 26396246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Two Novel
    Zhao X; Dai Q; Jia R; Zhu D; Liu M; Wang M; Chen S; Sun K; Yang Q; Wu Y; Cheng A
    Front Cell Infect Microbiol; 2017; 7():391. PubMed ID: 28929089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective Immunity Elicited by Oral Immunization of Mice with
    Erova TE; Kirtley ML; Fitts EC; Ponnusamy D; Baze WB; Andersson JA; Cong Y; Tiner BL; Sha J; Chopra AK
    Front Cell Infect Microbiol; 2016; 6():148. PubMed ID: 27891321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of CD8+ T lymphocytes by Salmonella typhimurium is independent of Salmonella pathogenicity island 1-mediated host cell death.
    Wijburg OL; Van Rooijen N; Strugnell RA
    J Immunol; 2002 Sep; 169(6):3275-83. PubMed ID: 12218147
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Purification of antibodies to O antigen of Salmonella Typhimurium from human serum by affinity chromatography.
    O'Shaughnessy CM; Micoli F; Gavini M; Goodall M; Cobbold M; Saul A; Maclennan CA
    J Immunol Methods; 2013 Jan; 387(1-2):199-210. PubMed ID: 23142459
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Roles of the
    Chen S; Liao C; Zhang C; Cheng X
    Can J Vet Res; 2018 Apr; 82(2):102-105. PubMed ID: 29755189
    [No Abstract]   [Full Text] [Related]  

  • 39. Role in virulence and protective efficacy in pigs of Salmonella enterica serovar Typhimurium secreted components identified by signature-tagged mutagenesis.
    Carnell SC; Bowen A; Morgan E; Maskell DJ; Wallis TS; Stevens MP
    Microbiology (Reading); 2007 Jun; 153(Pt 6):1940-1952. PubMed ID: 17526851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunogenicity of a Bivalent Adjuvanted Glycoconjugate Vaccine against
    Fiorino F; Rondini S; Micoli F; Lanzilao L; Alfini R; Mancini F; MacLennan CA; Medaglini D
    Front Immunol; 2017; 8():168. PubMed ID: 28289411
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.